







Amount of therapy matters in very early aphasia rehabilitation after stroke: A 
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Background and Aim 
The effects of very early aphasia therapy on recovery are equivocal. This paper 
examines predictors of very early aphasia recovery through statistical modelling. 
Methods: This study involved a secondary analysis of merged data from two 
randomized, single-blind trials conducted in Australian acute and subacute hospitals. 
Study 1(N=59) compared daily therapy to usual ward care (UC) for up to four weeks 
post-stroke, in patients with moderate-severe aphasia. Study 2(N=20) compared daily 
group therapy to daily individual therapy for 20 one-hour sessions over five weeks, in 
patients with mild-severe aphasia. The primary outcome measure was the WAB 
Aphasia Quotient (AQ) at therapy completion.  
This analysis used regression modelling to examine the effects of age, baseline AQ 
and baseline modified Rankin Scale (mRS), average therapy amount, therapy intensity 
and number of therapy sessions on aphasia recovery.  
Results: Baseline AQ (p=.047), average therapy amount (p=.030) and baseline mRS 
(p=.043) were significant predictors in the final regression model, which explained 30% 
(p<.001) of variance in aphasia recovery.  
Conclusion: The amount of very early aphasia therapy could significantly affect 
communication outcomes at 4-5 weeks post stroke. Further studies should include 






















  Aphasia is a devastating condition that affects hundreds of thousands of stroke 
survivors around the world each year1-3. Aphasia has well known negative impacts on 
the stroke survivor, family and community. These include increased mortality4 and 
reduced functional outcomes5, higher levels of depression and lower return to work6 
rates when compared to stroke survivors without aphasia7. Predicting aphasia 
recovery after stroke and the effect of aphasia on stroke recovery have long been the 
focus of discussion in the literature.1-5 Variability in the nature, severity and type of 
post-stroke aphasia1 and subsequent enormous variability in the amount, speed and 
extent of recovery that occurs in the months following stroke8 makes selecting the 
most appropriate amount, type and timing of aphasia therapy treatment for individuals 
with aphasia a difficult task. 
Complete aphasia recovery is reported to range from 11-74%2,3,8,9 of cases 
depending on the sensitivity of the outcome measure used and the length of recovery 
time post-stroke. Predicting aphasia recovery after stroke has received renewed 
attention in recent literature with papers examining early aphasia diagnosis and the 




recovery across time,2,3  using patient performance on language and cognitive tests to 
predict therapy gain in the chronic recovery phase5,8,10 and providing a comprehensive 
literature review of the variables considered important in aphasia recovery.11 
The ability to more reliably predict improved aphasia outcomes in individual 
stroke survivors may allow the benefit of limited aphasia rehabilitation services in 
clinical settings to be maximised. Predictors of aphasia recovery including vascular 
risk factors, stroke type, infarct volume/size and location, initial aphasia severity and 
type, age, gender, handedness, level of education, performance on language 
assessments and intelligence have all been investigated in an attempt to determine 
both stroke4,5 and aphasia outcomes1-3,8-10 at various points in the recovery journey. To 
date, however, there are no stroke related or personal characteristics that reliably 
predict aphasia recovery in an individual8 and a combination of the above factors has 
only accounted for between 32 and 41% of variability in recovery8. This suggests that 
other factors, critical in recovery, have not been accounted for, potentially including the 
type and timing of aphasia treatment. 
There remains a dearth of evidence around large-scale best-practice aphasia 
intervention. The authors of the recent Cochrane Review of Speech and Language 
Therapy following Stroke,12 concluded there was “some benefit of speech and 
language therapy following stroke in relation to functional communication, reading, 
comprehension, expressive language and writing”12(pp 39). The authors went on to warn 
of the dangers of over-interpreting this finding as the results in the meta-analysis were 
highly dependent on a single trial where there was “very limited information on the 
nature of the speech and language therapy intervention and the quality of research 
undertaken”12(pp 39). The results of the Cochrane Review12 do little to assist speech 
pathology practice in relation to the everyday application of the right amount of the 
right type of therapy for the right person at the right time in recovery, particularly in 




evidence to guide clinical practice in aphasia therapy after stroke. It is here that we 
find an abundance of high quality single-case design13-15 and small group studies16-18 
to support the provision of different types of aphasia therapy provided at various 
phases in the recovery journey. The vast majority of this research, however, does not 
include people with aphasia in the very early (within two weeks) and early (two to six 
weeks) post-stroke recovery phases (See examples of studies investigating very early 
and early intervention).13-18 
 Given the constant high demand for limited speech pathology services during 
(very) early recovery combined with the need to comply with health-funding regulators 
and the potential for therapy-induced recovery,19,20 it is crucial that speech pathologists 
deliver evidence-based efficient and efficacious aphasia therapy interventions. 
Unfortunately, current evidence based documents used to guide speech and language 
therapy practices21-23 in very early and early aphasia intervention after stroke raise 
more questions than they answer. A prime example of this is the question of “How 
much direct therapy?” particularly when considering the delicate nature of very early 
stroke recovery1,4 and limitations in service delivery that many speech pathology 
services report.24  
Positive effects have been found from very early aphasia therapy  in two small 
clinical randomised controlled trials19,20 and from two trials in early recovery25,26. Yet 
few if any studies have included the amount of aphasia therapy in early aphasia 
recovery as a possible predictor in models of improved communication outcomes in 
post-stroke aphasia. This paper specifically examines the role of the amount of very 








single-blind controlled trials which were conducted in Perth, Australia. The trials 
compared communication outcomes for two independent cohorts in the very early 
post-stroke recovery phase. The primary endpoint for this analysis was at therapy 
completion, which was a mean of 24 days (SD=12.3) post-stroke. These studies have 
been previously reported19,20 and the merged data are outlined below. 
Participants 
Participants were admitted to an acute care teaching hospital in metropolitan Perth, 
Western Australia and were recruited to the trials within 14 days following stroke if they 
met the following criteria: 
I. Diagnosed with an acute stroke by a stroke physician or neurologist 
II. The diagnosis was confirmed by computer tomography and/or magnetic 
resonance imaging within 48 hours of hospital admission 
III. Medical stability (Glasgow Coma Score > 10) 
IV. The patient could remain awake for at least 30 minutes and 
V. The patient scored less than 93.8 on the Aphasia Quotient (AQ) of the Western 
Aphasia Battery (WAB).27  
Patients were excluded from the trials if they: 
I. Had a previous diagnosis of aphasia 
II. Were unable to participate in therapy in English 
III. Had a mental illness or dementia 
IV. Had a previous history of sub-arachnoid and/or sub-dural haemorrhage or  
V. Had neurosurgical intervention and  
VI. uncorrected hearing or vision impairment. 
Assessments and baseline data   
The data in this analysis is from the baseline assessment and assessment 
immediately following treatment. This period ranged from 21 days to 51 days post 




participant and stroke characteristics for the 79 participants are outlined in Table 1.  
Amount and type of very early aphasia rehabilitation 
The amount of intervention provided to the participants in these trials varied greatly 
and has been outlined in detail19,20. All direct therapy was provided by a trained speech 
and language therapist. 
Trial 1 investigated therapy intensity and randomised individuals with moderate to 
severe aphasia to either daily therapy (DT) or standard ward based usual care (UC) 
for the duration of their inpatient stay (mean = 22 days). Those participants in the daily 
therapy group (N = 32)19 received a mean 7.5 sessions of 45 minutes of therapy over 
a period of 22 days. Twenty-three of the 27 participants randomised to UC (N = 27)19 
received no therapy during their acute hospital stay (mean = 22 days). The remaining 
four participants receiving UC in this trial received a collective total of 295 minutes (4.9 
hours) over a total of 7 sessions during the 22 days of the intervention period which 
equates to an average of 11 minutes of therapy.  
Trial 2 investigated the nature of very early aphasia therapy by comparing group 
versus individual therapy provided each day for up to 20 one-hour sessions over five 
weeks in patients (N=20) with mild-severe aphasia20. Participants in this trial were 
randomised to daily group therapy or daily 1:1 therapy and received a total of 356.75 
hours of therapy over 373 sessions. Participants received a mean of 18.65 sessions, 
which equated to a mean of 57 mins per session. On average, each participant in this 
trial received a total of 17.71 hours of therapy over a mean of 38.5 days. 
Therapy in Trial 1 and 2 aimed to increase verbal production of connected speech 
and was impairment based. Further description of the therapy provided to participants 
in each trial is outlined previously.19,20  
Trial 1: The treating therapists determined which therapy approach would be 
used and all therapies were provided as per published instructions. The therapies for 




therapy,28 Mapping Therapy29 and Semantic Feature Analysis (SFA)30 and adhered to 
principles of neurorehabilitation, incorporating repetitious trained activity together with 
facilitation of error-free learning. Additionally, all participants who received therapy in 
this trial attempted a picture description task at each session during the intervention 
phase. 
Trial 2: Group therapy was based on the Constraint Induced Language Therapy (CILT) 
outlined by Pulvermuller and colleagues.16,31 It took place in small groups of 2-4 
participants and one speech pathologist who provided language support appropriate to 
each participant's needs. The stimuli and language support were designed to 
accommodate all levels of aphasia severity in the same group.  
Individual therapy (1:1) was tailored to suit the individual needs of the participant. 
Based on the participant's assessment results, the treating therapist selected the 
appropriate therapy from SFA30, phonological feature therapy32, or Lexical-semantic 
(BOX) therapy28 or Mapping therapy.29 As per Trial 1,19 the treating therapists 
determined which therapy approach  would be used and all 1:1 therapies were 
provided as per published instructions. Participants received either a single therapy, or 
a combination of therapy types such as cued naming therapy and semantic feature 
therapy.  
 
Outcome assessment and Primary Outcome Measure  
Participants in both trials were assessed by qualified speech language therapists 
blinded to group allocation. Assessments were completed at acute hospital admission 
(baseline) and immediately following intervention (between four to five weeks post-
stroke). The primary outcome measure was the AQ score of the Western Aphasia 
Battery (WAB)27 at therapy completion.  




Duration of aphasia therapy was recorded by the treating therapists via the 
Allied Health System (AHS), a software package which records intervention in five 
minute units. Therapists recorded the amount of time spent on each intervention with 
each participant, including all time on communication related issues and on swallowing 
issues (as appropriate). The data presented here relate only to direct aphasia therapy 
provided to each participant. The data presented here do not include time spent on 
assessment, information provision, carer education, discharge planning or any other 
non-direct speech therapy intervention as described by Leff and Howard.33  
 
Average Therapy and Therapy Intensity Measures 
Average therapy, the average amount of therapy each participant received, was 
calculated by dividing the total therapy amount (in minutes) for all participants by the 
number of days in therapy (study duration). For both studies, the number of days in 
therapy reflected the total length of stay (seven days per week) regardless of the fact 
that rehabilitation was provided on five day per week regimen Therapy intensity, 
calculated by dividing the total therapy amount for all participants by the number of 
therapy sessions. We believed the average therapy amount and therapy intensity to be 




A linear regression model was developed to analyse the impact of amount and 
intensity of aphasia therapy on aphasia recovery.  
Predictors: 
The impact of the amount and intensity of aphasia therapy were investigated by 
including average therapy amount, therapy intensity and number of therapy sessions 




input, as per the Usual Care group in Trial 1. Other predictors added to the model 
were: baseline AQ to control for initial aphasia severity, the baseline mRS34 to control 
for stroke related disability and age as it is thought to be a predictor of aphasia 
recovery.  
Outcome Variable: 
The outcome variable for the regression model was the proportion of the potential 
maximal gain. This measure has previously been used by Lambon-Ralph et al10 and 
developed by Lazar et al.35 who called it percent of maximal achievable recovery. It is 
obtained by calculating the ratio of the achieved improvement in AQ score to the 
maximum attainable improvement at baseline. The ratio was then multiplied by 100 to 
convert it to a percent. This is represented in Figure 1 and is expressed as:  
 
 
This measure is preferred to raw AQ scores because it accounts for initial aphasia 
severity and has better statistical properties.36 Furthermore, it addresses the issue of 
ceiling effects of raw AQ scores.   
Model Development: 
The model was developed through a forward selection process. The selection protocol 
ensured that the predictor with the largest effect on the outcome variable was entered 
into the model first. Other variables were successively selected into the model based 
on the size of their effect on the outcome variable, relative to other predictors. The 
process stopped when entering additional variables to the model did not have a 
statistically significant impact on the outcome. 
The final model obtained through the forward selection process was verified by 
developing a model using backward elimination. Both forward selection and backward 






Seventy-nine cases were used in this study. Their baseline stroke and demographic 
characteristics are shown in Table 1. Nine participants (11%) were not included in the 
final regression model as they did not complete the end of therapy assessment. Seven 
of these participants died during the intervention period and two suffered significant 
stroke related medical complications. The mean (SD) participant age was 69.5 years 
(14.0); baseline AQ score was 31.7 (27.6) and mRS was 4.03 (.97). The mean (SD) 
total therapy amount was 392 minutes (468.3). The mean percent of maximal potential 
recovery for the group was 33.81 (30.95). Seventy cases were loaded into the final 
model. 
The Regression Model: 
The forward selection process yielded a regression model which explained 30% of the 
aphasia recovery (R2=0.294, p<0.001). Baseline AQ (B=0.29, p=0.047), initial stroke 
severity (B=-7.5, p=0.043) and average therapy amount (B=0.63, p=0.030) were found 
to be significant predictors aphasia recovery and were included in the final model. 
Conversely, therapy intensity, frequency of service and age did not have a significant 
effect, and did not feature in the final model. Therapy intensity and average therapy 
amount were highly correlated (r = 0.928, p < 0.001). Therefore, average therapy 
amount may be considered to be a surrogate measure for therapy intensity.  
Explaining the model: 
Details of the regression model are presented in Table 3. From a practical 
perspective, the model may be interpreted from the unstandardized coefficients. The 
unstandardized coefficient of 0.63 for average therapy amount suggests that after 
controlling for baseline AQ and initial stroke disability (mRS), a one minute increase in 
the average therapy amount would result in a 0.63% improvement in aphasia recovery. 




increase in average therapy amount, can be expected to improve recovery by 6.3%. In 
other words, if two patients present with the same baseline AQ and the same initial 
mRS, the patient who receives a higher amount of therapy per day in the very early 
rehabilitation phase, can be expected to have significantly better recovery. The model 
predicts that for every 10 minutes increase in therapy per day during the very early 
recovery period, the patient’s prognosis improves by 6.3%. Similarly, after controlling 
for initial stroke related disability, and average therapy amount, a person who scored 
10 points better on the WAB AQ at baseline had 2.9% better prognosis. Stroke related 
disability had a negative effect on aphasia recovery; an increase in stroke disability of 
one point on the mRS scale resulted in 7.5% poorer prognosis, after controlling for 
baseline aphasia and average therapy amount.  
The unstandardized coefficients provide a clinically useful and practical 
interpretation of the regression model. However, since each predictor is measured on 
a different scale, the sizes of the unstandardized coefficients are not indicative of the 
relative impact of each predictor on recovery. This information can be ascertained by 
looking at the standardised coefficients which are also presented in Table 3. The 
standardised coefficients are obtained by standardising the variables in the model to 
unit-less quantities with a standard deviation of one. These standardised coefficients 
are directly comparable and therefore provide better insight into the relative 
importance of each predictor in the model.36 As seen from Table 3, the standardised 
coefficient for the predictors in the model are β = 0.252 for baseline AQ, β = -0.243 for 
initial mRS and β = 0.245 for average therapy amount. The fact that three 
standardised coefficients are of approximately the same size (ignoring the negative 
sign of the coefficient for initial mRS) suggests that all three predictors have 
approximately the same impact on aphasia recovery.  
The specific values of the standardised coefficients may be interpreted as follows: 




0.252 standard deviations in percent of maximal recovery achieved. 
• An increase of one standard deviation in initial mRS results in a decrease of 
0.243 standard deviations in percent of maximal recovery achieved. 
• An increase of one standard deviation in average therapy amount per day 
results in an increase of 0.245 standard deviations in percent of maximal 
recovery achieved. 
Table 2 shows the standard deviations for these variables. Since the standard 
deviation for the percent of maximal potential recovery is 30.95, a 0.252 standard 
deviation increase corresponds to 7.8% increase in percent of potential maximal 
recovery. Since the standard deviation of baseline AQ is 27.3, this means that a 27.3 
point increase in AQ is associated with a 7.8% improvement in prognosis of recovery. 
Similarly, since the standard deviation of mRS is 1, a one category change in mRS is 
associated with a 0.243 standard deviation change in percent of maximal potential 
recovery, which corresponds to a 7.6% change in prognosis. Since the sign of the 
coefficient is negative, an increase in mRS is associated with poorer prognosis. Finally, 
the standard deviation for average therapy amount is 12.1 and the standardised 
coefficient is 0.245. This suggests that an increase of 12.1 minutes of therapy per day 
in the very early rehabilitation period will result in a 7.6% improvement in prognosis. In 
summary, this may be interpreted to mean that an approximately 8% difference in 
prognosis may be associated with either a 27 unit difference in baseline AQ of a 1 
category difference in mRS or a difference of 12 minutes of therapy per day, in the 
very early rehabilitation period.   
The partial and part correlation coefficients presented in Table 3 also confirm 
the fact that the relative importance of the three predictors in the model is 
approximately the same. The partial correlation coefficients represent the relationships 
between each predictor and the outcome variable, while controlling for the effects that 




the relationships between each predictor and the outcome variable, while controlling 
for the effect that each of the other predictors has on the outcome variable39. As seen 
from Table 3, the partial correlations for baseline AQ, initial mRS and average therapy 
amount are 0.242, -0.247 and 0.263 respectively, while the corresponding part 
correlations are 0.210, -0.214 and 0.229 respectively. Once again, the fact that these 
are of approximately the same size (ignoring the negative sign of the coefficients for 
mRS) suggests that after “factoring out” the effects of the other predictors in the model, 
each predictor has approximately the same correlation with the prognosis of recovery. 
It should be noted that the partial and part correlations of average therapy amount with 
recovery are marginally higher than those of baseline AQ and of initial mRS. Although 
these small differences are not likely to be statistically significant, they provide a 
promising direction for future investigation of the intensity of very early aphasia 
therapy. 
The clinical interpretation of this model is presented in Table 4 which 
demonstrates case examples for specific values of baseline mRS, and AQ scores. This 
model predicts the amount of change in the AQ score when no therapy, (spontaneous 
recovery) 30 and 60 minutes of therapy are provided within the very early aphasia 
recovery phase. For example the highlighted section in Table 4 gives the example of a 
person with a mRS of 4 and a baseline AQ score of 16 indicating significant stroke 
related disability and severe aphasia. Using this model to interpret the regression 
information presented in Tables 2 and 3, the person in this case example could expect 
spontaneous recovery to account for a 31 point increase (47-16) on the AQ after 22 – 
25 days of intervention. If the same person received  30 minutes of therapy, five days 
per week for the same period, they could expect to gain an extra 11 points on the AQ 
score (58-16) over and above what could be expected from spontaneous recovery. If 
that same person was to receive 60 minutes of direct aphasia therapy, for the same 




could be expected from spontaneous recovery. A twenty-two point gain on the AQ is 
both a statistically and clinically significant improvement which could be explained in a 
clinical setting as the difference between a person speaking in single words with poor 
comprehension requiring full assistance to communicate to talking independently in 
sentences with mild word finding difficulties. 
 
Discussion 
 This study is the first of its kind to include the amount of aphasia therapy as a 
factor in predicting aphasia recovery.  Importantly, the data only include the amount of 
time spent in direct therapy,33 which allows for some interpretation of the results  
regarding the intensity of aphasia therapy in very early aphasia recovery. Of great 
interest in this cohort are the stroke survivors (N=23; 29%) with aphasia who received 
no direct aphasia therapy in the first 22 days of their recovery (from Trial 1).19 This 
cohort and any change made in AQ scores between their baseline assessment and 
the end of the intervention period can be reliably attributed to spontaneous recovery.  
 The selection criteria for these trials were designed to be broadly inclusive to allow 
for reasonable external validity when interpreting the results. We believe the 
participants in these trials were representative of a typical stroke related aphasia 
caseload in very early and early recovery phases. Over half (N=44 or 56%) of the 
cohort experienced severe aphasia (score of between 0 – 32.2 on the AQ) and the age 
of the cohort in this study (69 years) sits within the age range (5935 to 761,9) of previous 
studies of aphasia recovery. However a natural variation in age is evident, the reason 
for the differences is unknown and may have some relationship with the region in 
which the studies were undertaken.  
 Lazar et al,35 outline a distinctive relationship between initial aphasia severity and 




aphasia. The authors35 report the proportion of maximal potential recovery in people 
with aphasia is similar to the amount of predicted and proportional recovery in motor 
impairment suggesting that “spontaneous recovery may have similar biological 
mechanisms, related to initial severity, across modalities.”(35pp1487) Due to the high 
predictability of acute stroke recovery, Lazar et al raise three alternative hypotheses 
regarding early treatment, these being: i) treatment induces a predictable relation with 
therapists providing intervention in direct proportion to impairment; ii) treatment has no 
effect on language recovery and iii)  treatment acts to trigger or enable spontaneous, 
biological recovery mechanisms. 
 We believe there are several elements from this study that support Lazar et al’s 
alternative hypotheses ii) and iii). Primarily, this study adds information regarding 
recovery in people with severe aphasia and that the model we have presented 
includes various amounts of direct aphasia therapy provided in the very early phase 
when the mechanisms of spontaneous recovery are said to be their greatest.37 
 From the model presented in this study, we can see that the expected effects of 
spontaneous recovery are significant. Given the data presented in this study, and the 
trend towards the positive effects of aphasia therapy12 hypothesis ii) “treatment has no 
effect on language recovery” may prove incorrect. Conversely, evidence to support 
Lazar et al’s35 hypothesis iii) “that treatment acts to trigger or enable spontaneous, 
biological recovery mechanisms” especially in the very early and early recovery 
phases is growing. This is evidenced by the data in this study which showed that the 
standardised coefficients for baseline AQ, initial mRS and average amount of therapy 
have approximately the same impact on aphasia recovery.  
 In view of the fact that initial aphasia severity and stroke disability are two factors 
to consistently predict aphasia recovery and that amount of aphasia therapy has not 
previously been included in predictive models, it is interesting to see that amount of 




factors of aphasia severity and stroke disability.   
 
Study Limitations 
As a preliminary attempt at modelling, the current model has a number of 
limitations. The number of factors used in this analysis includes only the major clinical 
predictors (not AQ subtest scores, gender or handedness) as there was insufficient 
power in the sample to include more. In addition, the end point of this analysis was 
calculated at therapy completion which does not allow for further interpretation of the 
possible long -term effects of the amount of very early intervention.  
Evidence for aphasia therapy effectiveness in the very early stage after onset is 
equivocal, despite the recent trend toward positive results. This study has drawn data 
from only the two positive studies completed in the very early recovery phase and as 
such the results should be interpreted with due caution. Due to difficulties with data-
pooling, differences in outcome measures and lack of reporting of data regarding direct 
aphasia intervention, studies that did not show a therapy effect38,39 were not 
considered.  
This model gives a scientifically sound estimation of factors that contribute to 
aphasia recovery, the model presented here accounts for approximately 30% of the 
variability seen in overall aphasia recovery, suggesting there is still much work to be 
done to identify the remaining undeclared factors that that contribute to aphasia 
recovery. Nonetheless, this type of modelling is a first attempt at providing systematic 
prediction of outcomes incorporating the important notion of treatment intensity. 
Numerous factors potentially contribute to recovery as previous studies have alluded 
to. It is proposed that future studies could systematically include many of these 






Conclusion and future directions 
The major contribution of this study is that the amount of aphasia therapy has 
been included in a predictive model investigating factors in aphasia recovery and it 
was shown to be a significant predictor with a similar impact on recovery as baseline 
aphasia severity and initial stroke related disability. The amount of direct aphasia 
therapy provided in the very early recovery phase was tolerated by the majority of 
participants and is thought to be a clinically appropriate amount of therapy in the acute 
recovery phase.  
In order to better address the issues around sample size and the prognostic 
value of individual factors in aphasia recovery, the aphasia research community 
require further international collaboration and data sharing initiatives such as VISTA-
Rehab.40 Researchers and clinicians should consider ways in which to record various 
aphasia related interventions that allow for the analysis of amount of direct aphasia 
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Table 1.   Baseline demographic and stroke characteristics for the cohort 
 
 N = 79 Number (%) 
     
Age 
 Mean (SD) 69.5 (14.0) 
 Minimum 25 
 Maximum 91   
Female    38 (48)   
Previous Stroke:  
 Yes   9 (11)       
Stroke type     
 Ischaemic  71 (90)    
 Haemorrhagic    8 (10)         
Stroke classification     
 PACs  22 (28)      
 TACs  48 (61)  
 PoCs    1 ( 1)   
 LACs    0  
 Non-classified41   8 (10)   
Stroke Hemisphere 
 Left   76 (96)  
 Right     3 ( 4)     
Admission mRS score       
 2   6 ( 8)   
 3 18 (23)     
 4 23 (29)     
 5 32 (40)  
Baseline raw AQ Scores  
 Mean (SD) 31.7 (27.6) 
 Minimum   0.0 
 Maximum 88.3 
Baseline AQ severity 
 Mild      (62.6 – 93.6) 12 (15) 
 Moderate (32.3 – 62.5) 23 (29) 
 Severe (0 – 32.2) 44 (56) 
   
PACs: partial anterior circulation stroke; TACs: total anterior circulation stroke; PoCs: posterior 





Table 2.   Descriptive Statistics for Aphasia Therapy and Outcomes 
 
  Entire Cohort Assessed at Therapy End 
   N = 79 N=70 
     
    
Amount of very early therapy (mins) 
 Mean (SD) 392.0 (468.3) 406.6 (466.1) 
 Minimum   0.0 0.0 
 Maximum 1415 1200 
Number of therapy sessions 
 Mean (SD)   7.9 (8.2) 8.3 (8.3) 
 Minimum   0.0 0.0 
 Maximum 21.0 21.0 
Length of Stay (days) 
 Mean (SD)  23.9 (11.3) 24.4 (11.8) 
 Minimum   5 5 
 Maximum  49 49 
Therapy Intensity (min/session) 
 Mean (SD)   29.5 (24.7) 30.1 (23.6) 
 Minimum   0.0 0.0 
 Maximum 88.4 75.0 
Average Therapy Amount (min/day) 
 Mean (SD)  13.5 (14.7) 13.2 (12.1) 
 Minimum 0.0 0.0 
 Maximum 83.2 34.3 
Initial mRS 
 Mean (SD) 4.0 (1.0) 4.0 (1.0) 
 Minimum   2  2 
 Maximum 5  5 
Baseline AQ Scores  
 Mean (SD) 31.7 (27.6) 32.0 (27.3) 
 Minimum   0.0  0.0 
 Maximum 88.3 88.3  
AQ at Therapy End 
 Mean (SD)   51.2 (33.7) 
 Minimum   0.0 
 Maximum   98.0  
Percent Max Potential Recovery 
 Mean (SD)   33.81 (30.95) 
 Minimum   -25.20 






Table 3. Final Regression Model showing the relationship between the dependent 
variable %MPR and predictors: Baseline AQ, Initial mRS and Average Therapy 
Amount  
 









Interval for B Correlations







Intercept 46.698 17.335  2.694 .009 12.087 81.309   
Baseline AQ .285 .141 .252 2.026 .047 .004 .566 .450 .242
Initial mRS -7.466 3.610 -.243 -2.068 .043 -14.674 -.259 -.385 -.247






Table 4. Predictive model with case examples of stroke disability (baseline mRS), 
aphasia severity (baseline AQ), and 0 minutes (spontaneous recovery), 30 minutes 
and 60 minutes of very early aphasia therapy.* 
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